• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌特异性死亡风险与公共医疗保险:来自中国的前瞻性队列研究

Oesophageal cancer-specific mortality risk and public health insurance: Prospective cohort study from China.

作者信息

Wu Xiang-Lin, Li Xiao-Sheng, Cheng Jing-Han, Deng Lin-Xin, Hu Zu-Hai, Qi Jun, Lei Hai-Ke

机构信息

Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China.

Chongqing Cancer Multi-omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, Chongqing 400030, China.

出版信息

World J Gastrointest Oncol. 2025 Apr 15;17(4):103629. doi: 10.4251/wjgo.v17.i4.103629.

DOI:10.4251/wjgo.v17.i4.103629
PMID:40235891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11995315/
Abstract

BACKGROUND

Oesophageal cancer is a significant health concern worldwide, with high incidence and mortality rates. In China, the disease burden is particularly high, accounting for a substantial proportion of oesophageal cancer cases and related deaths worldwide.

AIM

To explore the relationship between the mortality rate of oesophageal cancer patients and insurance type, out-of-pocket ratio, and the joint effects of insurance type and out-of-pocket ratio.

METHODS

The test was used to analyze patients' demographic and clinical characteristics. Multivariate logistic regression, the Cox proportional hazard model, and the competitive risk model were used to calculate the cumulative hazard ratios (HRs) of all-cause death and oesophageal cancer-specific death among patients with different types of insurance and out-of-pocket ratios.

RESULTS

Compared with patients covered by basic medical insurance for urban and rural residents, patients covered by urban employee basic medical insurance for urban workers (UEBMI) had a 23.30% increased risk of oesophageal cancer-specific death [HR = 1.233, 95% confidence interval (CI): 1.093-1.391, < 0.005]. Compared with patients in the low out-of-pocket ratio group, patients in the high out-of-pocket ratio group had a 25.80% reduction in the risk of oesophageal cancer-specific death (HR = 0.742, 95%CI: 0.6555-0.84, < 0.005). With each 10% increase in the out-of-pocket ratio, the risk of oesophageal cancer-specific death decreased by 10.10% in patients covered by UEBMI. However, the risk of oesophageal cancer-specific death increased by 26.90% in patients in the high out-of-pocket ratio group.

CONCLUSION

This study reveals the relationships of the specific mortality rate of patients with oesophageal cancer with the out-of-pocket ratio and medical insurance types as well as their combined effects. This study provides practical suggestions and guidance for the formulation of relevant policies in this area.

摘要

背景

食管癌是全球重大的健康问题,发病率和死亡率都很高。在中国,疾病负担尤为严重,占全球食管癌病例及相关死亡的很大比例。

目的

探讨食管癌患者死亡率与保险类型、自付比例以及保险类型和自付比例的联合效应之间的关系。

方法

采用 检验分析患者的人口统计学和临床特征。使用多因素逻辑回归、Cox 比例风险模型和竞争风险模型计算不同保险类型和自付比例患者全因死亡和食管癌特异性死亡的累积风险比(HR)。

结果

与城乡居民基本医疗保险覆盖的患者相比,城镇职工基本医疗保险(UEBMI)覆盖的患者食管癌特异性死亡风险增加 23.30%[HR = 1.233,95%置信区间(CI):1.093 - 1.391,< 0.005]。与低自付比例组患者相比,高自付比例组患者食管癌特异性死亡风险降低 25.80%(HR = 0.742,95%CI:0.6555 - 0.84,< 0.005)。在 UEBMI 覆盖的患者中,自付比例每增加 10%,食管癌特异性死亡风险降低 10.10%。然而,高自付比例组患者的食管癌特异性死亡风险增加了 26.90%。

结论

本研究揭示了食管癌患者的特异性死亡率与自付比例、医疗保险类型及其联合效应之间的关系。本研究为该领域相关政策的制定提供了实用建议和指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/11995315/cdd5acabf14f/103629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/11995315/cdd5acabf14f/103629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/11995315/cdd5acabf14f/103629-g001.jpg

相似文献

1
Oesophageal cancer-specific mortality risk and public health insurance: Prospective cohort study from China.食管癌特异性死亡风险与公共医疗保险:来自中国的前瞻性队列研究
World J Gastrointest Oncol. 2025 Apr 15;17(4):103629. doi: 10.4251/wjgo.v17.i4.103629.
2
Lung Cancer-Specific Mortality Risk and Public Health Insurance: A Prospective Cohort Study in Chongqing, Southwest China.肺癌特异性死亡率与公共健康保险:中国西南重庆的一项前瞻性队列研究。
Front Public Health. 2022 Apr 29;10:842844. doi: 10.3389/fpubh.2022.842844. eCollection 2022.
3
Public health insurance and the risk of cancer-specific mortality in patients with cervical cancer: A Chinese prospective cohort study.公共医疗保险与宫颈癌患者癌症特异性死亡率的关系:一项中国前瞻性队列研究。
Front Public Health. 2023 Mar 30;11:1121548. doi: 10.3389/fpubh.2023.1121548. eCollection 2023.
4
Association of public health insurance with cancer-specific mortality risk among patients with nasopharyngeal carcinoma: a prospective cohort study in China.公共医疗保险与中国鼻咽癌患者癌症特异性死亡率风险的关联:一项前瞻性队列研究。
Front Public Health. 2023 Jun 2;11:1020828. doi: 10.3389/fpubh.2023.1020828. eCollection 2023.
5
Disparities in Hepatocellular Carcinoma Survival by Insurance Status: A Population-Based Study in China.保险状况对肝细胞癌生存的影响差异:中国的一项基于人群的研究。
Front Public Health. 2021 Nov 5;9:742355. doi: 10.3389/fpubh.2021.742355. eCollection 2021.
6
Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.公共医疗保险与乳腺癌患者的癌症特异性死亡风险:一项中国的前瞻性队列研究。
Int J Cancer. 2021 Jan 1;148(1):28-37. doi: 10.1002/ijc.33183. Epub 2020 Jul 14.
7
Differences in medical costs among urban lung cancer patients with different health insurance schemes: a retrospective study.不同医疗保险方案的城市肺癌患者医疗费用差异:一项回顾性研究。
BMC Health Serv Res. 2022 May 7;22(1):612. doi: 10.1186/s12913-022-07957-9.
8
Disparities in outcomes associated with rural-urban insurance status in China among inpatient women with stroke: a registry-based cohort study.中国住院中风女性中城乡医保状况与治疗结果的差异:一项基于登记处的队列研究。
Ann Transl Med. 2019 Sep;7(18):426. doi: 10.21037/atm.2019.08.125.
9
The impact of an innovative payment method on medical expenditure, efficiency, and quality for inpatients with different types of medical insurance: evidence from a pilot city, China.创新支付方式对不同医保类型住院患者医疗支出、效率和质量的影响:来自中国试点城市的证据。
Int J Equity Health. 2024 Jun 5;23(1):115. doi: 10.1186/s12939-024-02196-2.
10
Insurance status impacts survival of hepatocellular carcinoma patients after liver resection.保险状况影响肝癌患者肝切除术后的生存。
Cancer Med. 2023 Aug;12(16):17037-17046. doi: 10.1002/cam4.6339. Epub 2023 Jul 16.

引用本文的文献

1
Insurance coverage and patient outcomes: Understanding changes in esophageal cancer treatment.保险覆盖范围与患者治疗结果:了解食管癌治疗的变化
World J Gastrointest Oncol. 2025 Jul 15;17(7):107154. doi: 10.4251/wjgo.v17.i7.107154.
2
Beyond numbers: Public health insurance and oesophageal cancer mortality risk.超越数字:公共医疗保险与食管癌死亡风险
World J Gastrointest Oncol. 2025 Jul 15;17(7):107460. doi: 10.4251/wjgo.v17.i7.107460.

本文引用的文献

1
The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data.政府报销谈判对中国靶向抗癌药物使用和成本的影响:基于国家医疗保险数据的队列研究。
J Glob Health. 2023 Aug 11;13:04083. doi: 10.7189/jogh.13.04083.
2
Achievements and Challenges of the Healthcare System in China.中国医疗体系的成就与挑战。
Cureus. 2023 May 15;15(5):e39030. doi: 10.7759/cureus.39030. eCollection 2023 May.
3
Acupuncture effect on dumping syndrome in esophagus cancer patients with feeding jejunostomy: A study protocol for a single blind randomized control trial.
针刺对食管癌术后进食空肠造瘘患者倾倒综合征的影响:一项单盲随机对照试验研究方案。
Medicine (Baltimore). 2023 Jun 9;102(23):e33895. doi: 10.1097/MD.0000000000033895.
4
Association between physical activity and cancer risk among Chinese adults: a 10-year prospective study.体力活动与中国成年人癌症风险之间的关联:一项为期 10 年的前瞻性研究。
Int J Behav Nutr Phys Act. 2022 Dec 12;19(1):150. doi: 10.1186/s12966-022-01390-1.
5
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first-line treatment for advanced esophageal cancer.帕博利珠单抗联合化疗与单纯化疗作为晚期食管癌一线治疗的成本效果分析。
Cancer Med. 2023 Mar;12(5):6182-6189. doi: 10.1002/cam4.5350. Epub 2022 Oct 21.
6
Burden of esophageal cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.2019 年全球 204 个国家和地区食管癌发病和死亡负担及其归因危险因素分析。
Front Public Health. 2022 Sep 6;10:952087. doi: 10.3389/fpubh.2022.952087. eCollection 2022.
7
Impact of Medicaid Expansion on Incidence and Mortality from Gastric and Esophageal Cancer.医疗补助扩大对胃癌和食管癌发病率及死亡率的影响。
Dig Dis Sci. 2023 Apr;68(4):1178-1186. doi: 10.1007/s10620-022-07659-6. Epub 2022 Aug 16.
8
Lung Cancer-Specific Mortality Risk and Public Health Insurance: A Prospective Cohort Study in Chongqing, Southwest China.肺癌特异性死亡率与公共健康保险:中国西南重庆的一项前瞻性队列研究。
Front Public Health. 2022 Apr 29;10:842844. doi: 10.3389/fpubh.2022.842844. eCollection 2022.
9
Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study.中国五种常见癌症诊断时分期的差异:一项多中心、基于医院的观察性研究。
Lancet Public Health. 2021 Dec;6(12):e877-e887. doi: 10.1016/S2468-2667(21)00157-2.
10
Predictive Model for Overall Survival and Cancer-Specific Survival in Patients with Esophageal Adenocarcinoma.食管腺癌患者总生存期和癌症特异性生存期的预测模型
J Oncol. 2021 Sep 14;2021:4138575. doi: 10.1155/2021/4138575. eCollection 2021.